Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Cancers (Basel). 2010 Dec 30;3(1):126-63. doi: 10.3390/cancers3010126.
Metastasis accounts for the vast majority of morbidity and mortality associated with melanoma. Evidence suggests melanoma has a predilection for metastasis to particular organs. Experimental analyses have begun to shed light on the mechanisms regulating melanoma metastasis and organ specificity, but these analyses are complicated by observations of metastatic dormancy and dissemination of melanocytes that are not yet fully malignant. Additionally, tumor extrinsic factors in the microenvironment, both at the site of the primary tumor and the site of metastasis, play important roles in mediating the metastatic process. As metastasis research moves forward, paradigms explaining melanoma metastasis as a step-wise process must also reflect the temporal complexity and heterogeneity in progression of this disease. Genetic drivers of melanoma as well as extrinsic regulators of disease spread, particularly those that mediate metastasis to specific organs, must also be incorporated into newer models of melanoma metastasis.
转移是导致黑色素瘤发病率和死亡率高的主要原因。有证据表明黑色素瘤容易转移到特定的器官。实验分析已经开始揭示调控黑色素瘤转移和器官特异性的机制,但这些分析受到黑色素瘤休眠和非完全恶性黑素细胞扩散的观察结果的影响。此外,微环境中的肿瘤外在因素,无论是在原发肿瘤部位还是转移部位,都在介导转移过程中发挥着重要作用。随着转移研究的进展,解释黑色素瘤转移为逐步过程的范例也必须反映出该疾病进展的时间复杂性和异质性。黑色素瘤的遗传驱动因素以及疾病传播的外在调节因子,特别是那些介导特定器官转移的因子,也必须被纳入黑色素瘤转移的新模型中。